Daniel Hohl

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil

181 publications

2021 | 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1988 | 1987 |
Mutually exclusive lymphangiogenesis or perineural infiltration in human skin squamous-cell carcinoma.
Schaller J., Hajjami H.M., Rusakiewicz S., Ioannidou K., Piazzon N., Miles A., Golshayan D., Gaide O., Hohl D., Speiser D.E. et al., 2021/03/30. Oncotarget, 12 (7) pp. 638-648. Peer-reviewed.
Eccrine naevus: Case report with dermoscopic findings.
Ventéjou S., Hohl D., Bogiatzi S., Christen-Zaech S., Morren M.A., 2021/03. Annales de dermatologie et de venereologie, 148 (1) pp. 66-68. Peer-reviewed.
Case Report: Pansclerotic Morphea-Clinical Features, Differential Diagnoses and Modern Treatment Concepts.
Ventéjou S., Schwieger-Briel A., Nicolai R., Christen-Zaech S., Schnider C., Hofer M., Bogiatzi S., Hohl D., De Benedetti F., Morren M.A., 2021. Frontiers in immunology, 12 p. 656407. Peer-reviewed.
Birt-Hogg-Dubé syndrome.
Daccord C., Good J.M., Morren M.A., Bonny O., Hohl D., Lazor R., 2020/09/30. European respiratory review, 29 (157) p. 200042. Peer-reviewed.
Palmoplantar Keratoderma with Leukokeratosis Anogenitalis Caused by KDSR Mutations.
Huber M., Chiticariu E., Bachmann D., Flatz L., Hohl D., 2020/08. The Journal of investigative dermatology, 140 (8) pp. 1662-1665.e1. Peer-reviewed.
Bilateral Alopecia in a Six-year-old Boy: A Quiz.
Ventéjou S., Morren M.A., George K., Vernez M., Hohl D., Christen-Zäch S., 2020/04/06. Acta dermato-venereologica, 100 (8) pp. adv00104. Peer-reviewed.
CENPV Is a CYLD-Interacting Molecule Regulating Ciliary Acetylated α-Tubulin.
Chiticariu E., Regamey A., Huber M., Hohl D., 2020/01. The Journal of investigative dermatology, 140 (1) pp. 66-74.e4. Peer-reviewed.
Unclassified sclerosing malignant melanomas with AKAP9-BRAF gene fusion: a report of two cases and review of BRAF fusions in melanocytic tumors.
Perron E., Pissaloux D., Neub A., Hohl D., Tartar M.D., Mortier L., Alberti L., de la Fouchardiere A., 2018/03. Virchows Archiv, 472 (3) pp. 469-476. Peer-reviewed.
Shed Skin Cancer, Not Collagen XVII: A New Approach to Targeting Skin Cancer Progression.
Gaide O., Hohl D., 2018/01/03. Molecular therapy, 26 (1) pp. 8-9. Peer-reviewed.
Maladies vasculaires rares, mise en place d’un centre multidisciplinaire spécialisé au CHUV [Rare vascular diseases, building dedicated multidisciplinary specialized center]
Krieger C., Baud D., Bouchardy J., Christen-Zaech S., De Buys A., Deglise S., El Ezzi O., Fresa M., Hofer M., Hohl D. et al., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2109-2115. Peer-reviewed.
Skin Colonization by Staphylococcus aureus Precedes the Clinical Diagnosis of Atopic Dermatitis in Infancy.
Meylan P., Lang C., Mermoud S., Johannsen A., Norrenberg S., Hohl D., Vial Y., Prod'hom G., Greub G., Kypriotou M. et al., 2017/12. The Journal of investigative dermatology, 137 (12) pp. 2497-2504. Peer-reviewed.
Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas
Bal Elodie, Park Hyun-Sook, Belaid-Choucair Zakia, Kayserili Hülya, Naville Magali, Madrange Marine, Chiticariu Elena, Hadj-Rabia Smail, Cagnard Nicolas, Kuonen Francois et al., 2017/10. Nature Medicine, 23 (10) pp. 1226-1233.
Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas.
Bal E., Park H.S., Belaid-Choucair Z., Kayserili H., Naville M., Madrange M., Chiticariu E., Hadj-Rabia S., Cagnard N., Kuonen F. et al., 2017/10. Nature medicine, 23 (10) pp. 1226-1233. Peer-reviewed.
Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra Pilaris.
Feldmeyer L., Mylonas A., Demaria O., Mennella A., Yawalkar N., Laffitte E., Hohl D., Gilliet M., Conrad C., 2017/04/01. JAMA dermatology, 153 (4) pp. 304-308. Peer-reviewed.
Unusual dermatological presentation and immune phenotype in SCID due to an IL7R mutation: the value of whole-exome sequencing and the potential benefit of newborn screening.
Marquardt L., Lacour M., Hoernes M., Opitz L., Lecca R., Volkmer B., Reichenbach J., Hohl D., Ansari M., Ozsahin H. et al., 2017/03. Journal of the European Academy of Dermatology and Venereology, 31 (3) pp. e147-e148. Peer-reviewed.
Activin promotes skin carcinogenesis by attraction and reprogramming of macrophages.
Antsiferova M., Piwko-Czuchra A., Cangkrama M., Wietecha M., Sahin D., Birkner K., Amann V.C., Levesque M., Hohl D., Dummer R. et al., 2017/01. EMBO molecular medicine, 9 (1) pp. 27-45. Peer-reviewed.
5-Hydroxymethylcytosine Expression in Proliferative Nodules Arising within Congenital Nevi Allows Differentiation from Malignant Melanoma.
Pavlova O., Fraitag S., Hohl D., 2016/12. The Journal of investigative dermatology, 136 (12) pp. 2453-2461. Peer-reviewed.
Cutaneous presentation of hepatosplenic T-cell lymphoma-a potential mimicker of primary cutaneous gamma-delta T-cell lymphoma.
Karpate A., Barcena C., Hohl D., Bisig B., de Leval L., 2016/11. Virchows Archiv : an international journal of pathology, 469 (5) pp. 591-596. Peer-reviewed.
Colonisation of basal cell carcinoma by lentigo maligna: a case report, review of the literature, and series follow-up.
Kuonen F., Aschwanden J., Dimaio D.J., Elston D.M., Gilliet M., Hohl D., Gaide O., 2016/10/01. European journal of dermatology : EJD, 26 (5) pp. 465-469. Peer-reviewed.
Use of emollient in atopic dermatitis prevention.
D'Erme A.M., Hohl D., 2016/07. Dermatologic therapy, 29 (4) pp. 286-287. Peer-reviewed.
Keratoacanthoma: a distinct entity?
Gleich T., Chiticariu E., Huber M., Hohl D., 2016/02. Experimental dermatology, 25 (2) pp. 85-91. Peer-reviewed.
Defects in Stratum Corneum Desquamation Are the Predominant Effect of Impaired ABCA12 Function in a Novel Mouse Model of Harlequin Ichthyosis.
Zhang L., Ferreyros M., Feng W., Hupe M., Crumrine D.A., Chen J., Elias P.M., Holleran W.M., Niswander L., Hohl D. et al., 2016. PloS one, 11 (8) pp. e0161465. Peer-reviewed.
HOPX: The Unusual Homeodomain-Containing Protein.
Mariotto A., Pavlova O., Park H.S., Huber M., Hohl D., 2016. Journal of Investigative Dermatology, 136 (5) pp. 905-911.
Identification of a novel PPARβ/δ/miR-21-3p axis in UV-induced skin inflammation.
Degueurce G., D'Errico I., Pich C., Ibberson M., Schütz F., Montagner A., Sgandurra M., Mury L., Jafari P., Boda A. et al., 2016. EMBO Molecular Medicine, 8 (8) pp. 919-936. Peer-reviewed.
Late-Onset Multiple Self-Healing Squamous Epithelioma Ferguson-Smith Recurrence Induced by Radiotherapy.
Feldmeyer L., Szeverényi I., Mandallaz M., Lane E.B., Hohl D., 2016. Case reports in dermatology, 8 (3) pp. 344-349. Peer-reviewed.
PASS Syndrome: An IL-1-Driven Autoinflammatory Disease.
Leuenberger M., Berner J., Di Lucca J., Fischer L., Kaparos N., Conrad C., Hohl D., So A., Gilliet M., 2016. Dermatology (Basel, Switzerland), 232 (2) pp. 254-258. Peer-reviewed.
Keratoacanthoma: A distinct entity?
Gleich T., Chiticariu E., Huber M., Hohl D., 2015. Experimental Dermatology.
Nrf2 Activation Promotes Keratinocyte Survival during Early Skin Carcinogenesis via Metabolic Alterations.
Rolfs F., Huber M., Kuehne A., Kramer S., Haertel E., Muzumdar S., Wagner J., Tanner Y., Böhm F., Smola S. et al., 2015. Cancer Research, 75 (22) pp. 4817-4829. Peer-reviewed.
The TRAF-interacting protein (TRAIP) is a novel E2F target with peak expression in mitosis.
Chapard C., Hohl D., Huber M., 2015. Oncotarget, 6 (25) pp. 20933-20945. Peer-reviewed.
Increased epidermal expression and absence of mutations in CARD14 in a series of patients with sporadic pityriasis rubra pilaris.
Eytan O., Qiaoli L., Nousbeck J., van Steensel M.A., Burger B., Hohl D., Taïeb A., Prey S., Bachmann D., Avitan-Hersh E. et al., 2014. British Journal of Dermatology, 170 (5) pp. 1196-1198.
New and recurrent AAGAB mutations in punctate palmoplantar keratoderma.
Pohler E., Huber M., Boonen S.E., Zamiri M., Gregersen P.A., Sommerlund M., Ramsing M., Hohl D., McLean W.H., Smith F.J., 2014. British Journal of Dermatology, 171 (2) pp. 433-436.
Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer.
Montagner A., Delgado M.B., Tallichet-Blanc C., Chan J.S., Sng M.K., Mottaz H., Degueurce G., Lippi Y., Moret C., Baruchet M. et al., 2014. EMBO Molecular Medicine, 6 (1) pp. 80-98.
TRAIP is a regulator of the spindle assembly checkpoint.
Chapard C., Meraldi P., Gleich T., Bachmann D., Hohl D., Huber M., 2014. Journal of Cell Science, 127 (24) pp. 5149-5156. Peer-reviewed.
UVB-Induced Skin Inflammation and Cutaneous Tissue Injury Is Dependent on the MHC Class I-Like Protein, CD1d.
Ryser S., Schuppli M., Gauthier B., Hernandez D.R., Roye O., Hohl D., German B., Holzwarth J.A., Moodycliffe A.M., 2014. Journal of Investigative Dermatology, 134 (1) pp. 192-202.
Activin a inhibits antigen-induced allergy in murine epicutaneous sensitization.
Kypriotou M., Rivero D., Haller S., Mariotto A., Huber M., Acha-Orbea H., Werner S., Hohl D., 2013. Frontiers in Immunology, 4 (246) pp. 1-10.
Dual role of the antioxidant enzyme peroxiredoxin 6 in skin carcinogenesis.
Rolfs F., Huber M., Gruber F., Böhm F., Pfister H.J., Bochkov V.N., Tschachler E., Dummer R., Hohl D., Schäfer M. et al., 2013. Cancer Research, 73 (11) pp. 3460-3469.
EBV+ cutaneous B-cell lymphoproliferation of the leg in an elderly patient with mycosis fungoides and methotrexate treatment.
Rausch T., Cairoli A., Benhattar J., Spring P., Hohl D., de Leval L., 2013. Apmis : Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 121 (1) pp. 79-84.
Ichthyosen : Pathophysiologische Modelle der epidermalen Differenzierung [The ichthyoses : Pathophysiological models of epidermal differentiation].
Hohl D., Huber M., 2013. Der Hautarzt, 64 (1) pp. 12-21.
Identification of the first nonsense CDSN mutation with expression of a truncated protein causing peeling skin syndrome type B.
Mallet A., Kypriotou M., George K., Leclerc E., Rivero D., Mazereeuw-Hautier J., Serre G., Huber M., Jonca N., Hohl D., 2013. British Journal of Dermatology, 169 (6) pp. 1322-1325.
Large agminated cellular 'plaque-type' blue nevus surrounding the ear: a case and review.
Spring P., Perrier P., Erba P., Hagmann P., Mihm M.C., Hohl D., 2013. Dermatology, 227 (1) pp. 21-25.
Localized interstitial granuloma annulare induced by subcutaneous injections for desensitization.
Spring P., Vernez M., Maniu C.M., Hohl D., 2013. Dermatology Online Journal, 19 (6) p. 18572.
Mast cells are dispensable for normal and activin-promoted wound healing and skin carcinogenesis.
Antsiferova M., Martin C., Huber M., Feyerabend T.B., Förster A., Hartmann K., Rodewald H.R., Hohl D., Werner S., 2013. Journal of Immunology, 191 (12) pp. 6147-6155.
Spontaneous Atopic Dermatitis-Like Symptoms in a/a ma ft/ma ft/J Flaky Tail Mice Appear Early after Birth.
Kypriotou M., Boéchat C., Huber M., Hohl D., 2013. Plos One, 8 (7) pp. e67869.
Syndrome of birt-hogg-dubé, a histopathological pitfall with similarities to tuberous sclerosis: a report of three cases.
Spring P., Fellmann F., Giraud S., Clayton H., Hohl D., 2013. American Journal of Dermatopathology, 35 (2) pp. 241-245.
Basal cell carcinoma - molecular biology and potential new therapies.
Kasper M., Jaks V., Hohl D., Toftgård R., 2012. Journal of Clinical Investigation, 122 (2) pp. 455-463.
Définir le risque du carcinome spinocellulaire: rôle de la clinique et du rapport anatomopathologique [Risk of cutaneous squamous cell carcinomas: the role of clinical and pathological reports].
Chollet A., Hohl D., Perrier P., 2012. Revue Médicale Suisse, 8 (335) pp. 743-746.
Nrf2 links epidermal barrier function with antioxidant defense.
Schäfer M., Farwanah H., Willrodt A.H., Huebner A.J., Sandhoff K., Roop D., Hohl D., Bloch W., Werner S., 2012. EMBO Molecular Medicine, 4 (5) pp. 364-379.
The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the 'fused genes' family.
Kypriotou M., Huber M., Hohl D., 2012. Experimental Dermatology, 21 (9) pp. 643-649. Peer-reviewed.
The role of the TRAF-interacting protein in proliferation and differentiation.
Chapard C., Hohl D., Huber M., 2012. Experimental Dermatology, 21 (5) pp. 321-326. Peer-reviewed.
Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response.
Antsiferova M., Huber M., Meyer M., Piwko-Czuchra A., Ramadan T., MacLeod A.S., Havran W.L., Dummer R., Hohl D., Werner S., 2011. Nature Communications, 2 p. 576.
Homeodomain-only protein HOP is a novel modulator of late differentiation in keratinocytes.
Obarzanek-Fojt M., Favre B., Kypriotou M., Ryser S., Huber M., Hohl D., 2011. European Journal of Cell Biology, 90 (4) pp. 279-290. Peer-reviewed.
Induction of p38, tumour necrosis factor-α and RANTES by mechanical stretching of keratinocytes expressing mutant keratin 10R156H.
Obarzanek-Fojt M., Favre B., Huber M., Ryser S., Moodycliffe A.M., Wipff P.J., Hinz B., Hohl D., 2011. British Journal of Dermatology, 164 (1) pp. 125-134.
The TRAF-interacting protein (TRIP) is a regulator of keratinocyte proliferation.
Almeida S., Ryser S., Obarzanek-Fojt M., Hohl D., Huber M., 2011. Journal of Investigative Dermatology, 131 (2) pp. 349-357.
Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin.
Dumortier A., Durham A.D., Di Piazza M., Vauclair S., Koch U., Ferrand G., Ferrero I., Demehri S., Song L.L., Farr A.G. et al., 2010. PLoS One, 5 (2) pp. e9258.
Dermatologie. 2009: quoi de neuf en dermatologie [Dermatology]
Hohl D., 2010. Revue Médicale Suisse, 6 (231) pp. 15-17.
Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study.
Marazza G., Pham H.C., Schärer L., Pedrazzetti P.P., Hunziker T., Trüeb R.M., Hohl D., Itin P., Lautenschlager S., Naldi L. et al., 2009. British Journal of Dermatology, 161 (4) pp. 861-868.
Loss of serum response factor in keratinocytes results in hyperproliferative skin disease in mice.
Koegel H., von Tobel L., Schäfer M., Alberti S., Kremmer E., Mauch C., Hohl D., Wang X.J., Beer H.D., Bloch W. et al., 2009. Journal of Clinical Investigation, 119 (4) pp. 899-910.
Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis.
Wen Y., Liu Y., Xu Y., Zhao Y., Hua R., Wang K., Sun M., Li Y., Yang S., Zhang X.J. et al., 2009. Nature Genetics, 41 (2) pp. 228-233. Peer-reviewed.
Multiple comedonelike lesions encircling the anal orifice--quiz case.
Lurati M.C., Hohl D., 2009. Archives of Dermatology, 145 (12) pp. 1447-1452.
Novel and recurring ABCA12 mutations associated with harlequin ichthyosis: implications for prenatal diagnosis.
Thomas A.C., Sinclair C., Mahmud N., Cullup T., Mellerio J.E., Harper J., Dale B.A., Turc-Carel C., Hohl D., McGrath J.A. et al., 2008/11. British Journal of Dermatology, 158 (3) pp. 611-613. Peer-reviewed.
Evaluation of the Euromelanoma skin cancer screening campaign: the Swiss experience.
Bulliard J.L., Maspoli M., Panizzon R.G., Hohl D., Gueissaz F., Levi F., 2008/03. Journal of the European Academy of Dermatology and Venereology, 22 (3) pp. 365-366. Peer-reviewed.
Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling.
Malanchi I., Peinado H., Kassen D., Hussenet T., Metzger D., Chambon P., Huber M., Hohl D., Cano A., Birchmeier W. et al., 2008. Nature, 452 (7187) pp. 650-653.
Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity.
Almeida S., Maillard C., Itin P., Hohl D., Huber M., 2008. Journal of Investigative Dermatology, 128 (3) pp. 587-593.
Human epidermal Langerhans cells express the tight junction protein claudin-1 and are present in human genetic claudin-1 deficiency (NISCH syndrome).
Zimmerli S.C., Kerl K., Hadj-Rabia S., Hohl D., Hauser C., 2008. Experimental Dermatology, 17 (1) pp. 20-23.
La consultation génétique en dermatologie: une approche pratique [Genetic dermatology clinics: a practical approach]
Hohl D., Fellmann F., 2008. Revue Médicale Suisse, 4 (155) pp. 1084-1088.
Simultaneous manifestation of variegate porphyria in monozygotic twins.
Borradori L., Van Tuyll van Serooskerken A.M., Abraham S., Hohl D., Schneider-Yin X., Minder E., Frank J., 2008. British Journal of Dermatology, 159 (2) pp. 503-505.
UV irradiation of human keratinocytes activates the inflammasome
Beer H. D., Feldmeyer L., Keller M., Hohl D., Werner S., 2008. pp. S68-S68 dans 37th Annual Meeting of the European Society Dermatological Research, Journal of Investigative Dermatology. Peer-reviewed.
Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases
Lefort K., Mandinova A., Ostano P., Kolev V., Calpini V., Kolfschoten I., Devgan V., Lieb J., Raffoul W., Hohl D. et al., 2007/03. Genes and Development, 21 (5) pp. 562-77.
SLURP1 is a late marker of epidermal differentiation and is absent in Mal de Meleda
Favre B., Plantard L., Aeschbach L., Brakch N., Christen-Zaech S., de Viragh P. A., Sergeant A., Huber M., Hohl D., 2007/02. Journal of Investigative Dermatology, 127 (2) pp. 301-8.
The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes.
Feldmeyer L., Keller M., Niklaus G., Hohl D., Werner S., Beer H.D., 2007. Current Biology, 17 (13) pp. 1140-1155. Peer-reviewed.
Histone acetyltransferase HBO1 inhibits NF-kappaB activity by coactivator sequestration
Contzler R., Regamey A., Favre B., Roger T., Hohl D., Huber M., 2006/11. Biochemical and Biophysical Research Communications, 350 (1) pp. 208-13.
Pseudoxanthoma elasticum: evaluation of diagnostic criteria based on molecular data
Christen-Zach S., Huber M., Struk B., Lindpaintner K., Munier F., Panizzon R. G., Hohl D., 2006/07. British Journal of Dermatology, 155 (1) pp. 89-93.
Confirmation of the origin of NISCH syndrome
Feldmeyer L., Huber M., Fellmann F., Beckmann J. S., Frenk E., Hohl D., 2006/05. Human Mutation, 27 (5) pp. 408-10.
Nrf transcription factors in keratinocytes are essential for skin tumor prevention but not for wound healing
auf dem Keller U., Huber M., Beyer T. A., Kumin A., Siemes C., Braun S., Bugnon P., Mitropoulos V., Johnson D. A., Johnson J. A. et al., 2006/05. Molecular and Cellular Biology, 26 (10) pp. 3773-84.
A human keratin 10 knockout causes recessive epidermolytic hyperkeratosis
Muller F. B., Huber M., Kinaciyan T., Hausser I., Schaffrath C., Krieg T., Hohl D., Korge B. P., Arin M. J., 2006/04. Human Molecular Genetics, 15 (7) pp. 1133-41.
Clinical variation in X-linked dominant chondrodysplasia punctata (X-linked dominant ichthyosis)
Feldmeyer L., Mevorah B., Grzeschik K. H., Huber M., Hohl D., 2006/04. British Journal of Dermatology, 154 (4) pp. 766-769.
Formation of the cornified envelope
Hohl D., 2005/10. Experimental Dermatology, 14 (10) pp. 777-80.
Molecular genetics of pseudoxanthoma elasticum: type and frequency of mutations in ABCC6
Miksch S., Lumsden A., Guenther U. P., Foernzler D., Christen-Zach S., Daugherty C., Ramesar R. K., Lebwohl M., Hohl D., Neldner K. H. et al., 2005/09. Human Mutation, 26 (3) pp. 235-48.
Cornulin, a new member of the "fused gene" family, is expressed during epidermal differentiation
Contzler R., Favre B., Huber M., Hohl D., 2005/05. Journal of Investigative Dermatology, 124 (5) pp. 990-7.
Isolation and characterization of human repetin, a member of the fused gene family of the epidermal differentiation complex
Huber M., Siegenthaler G., Mirancea N., Marenholz I., Nizetic D., Breitkreutz D., Mischke D., Hohl D., 2005/05. Journal of Investigative Dermatology, 124 (5) pp. 998-1007.
Novel mutation of connexin 31 causing erythrokeratoderma variabilis
Feldmeyer L., Plantard L., Mevorah B., Huber M., Hohl D., 2005/05. British Journal of Dermatology, 152 (5) pp. 1072-1074.
Traitement de la dermatite atopique: approche pratique. [Treatment of atopic dermatitis: practical approach]
Rossetti G., Laffitte E., Eigenmann P. A., Lubbe J., Hohl D., Hofer M. F., 2005/02. Revue Médicale Suisse, 1 (7) pp. 501-4.
Hidradenite eccrine a Pseudomonas de l'enfant revelatrice d'une leucemie aigue lymphoblastique. [Pseudomonas eccrine hidradenitis in a child revealing acute lymphoblastic leukemia]
Laffitte E., Hohl D., Panizzon R. G., 2004/11. Annales de Dermatologie et de Venereologie, 131 (11) pp. 975-8.
Epidermal detachment, desmosomal dissociation, and destabilization of corneodesmosin in Spink5-/- mice
Yang T., Liang D., Koch P. J., Hohl D., Kheradmand F., Overbeek P. A., 2004/10. Genes and Development, 18 (19) pp. 2354-8.
Infection with Human Papillomavirus alters expression of the small proline rich proteins 2 and 3
Lehr E., Hohl D., Huber M., Brown D., 2004/03. Journal of Medical Virology, 72 (3) pp. 478-83.
Molecular consequences of deletion of the cytoplasmic domain of bullous pemphigoid 180 in a patient with predominant features of epidermolysis bullosa simplex
Fontao L., Tasanen K., Huber M., Hohl D., Koster J., Bruckner-Tuderman L., Sonnenberg A., Borradori L., 2004/01. Journal of Investigative Dermatology, 122 (1) pp. 65-72.
Severe Stevens-Johnson syndrome induced by contrast medium iopentol (Imagopaque).
Laffitte E., Nenadov Beck M., Hofer M., Hohl D., Panizzon R.G., 2004. British journal of dermatology, 150 (2) pp. 376-378. Peer-reviewed.
Molecular interaction of connexin 30.3 and connexin 31 suggests a dominant-negative mechanism associated with erythrokeratodermia variabilis
Plantard L., Huber M., Macari F., Meda P., Hohl D., 2003/12. Human Molecular Genetics, 12 (24) pp. 3287-94.
The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor
Regamey A., Hohl D., Liu J. W., Roger T., Kogerman P., Toftgard R., Huber M., 2003/12. Journal of Experimental Medicine, 198 (12) pp. 1959-64.
Cross-linked envelopes in nail plate in lamellar ichthyosis
Rice R. H., Crumrine D., Hohl D., Munro C. S., Elias P. M., 2003/11. British Journal of Dermatology, 149 (5) pp. 1050-1054.
Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda
Chimienti F., Hogg R. C., Plantard L., Lehmann C., Brakch N., Fischer J., Huber M., Bertrand D., Hohl D., 2003/11. Human Molecular Genetics, 12 (22) pp. 3017-24.
LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome
Bitoun E., Micheloni A., Lamant L., Bonnart C., Tartaglia-Polcini A., Cobbold C., Al Saati T., Mariotti F., Mazereeuw-Hautier J., Boralevi F. et al., 2003/10. Human Molecular Genetics, 12 (19) pp. 2417-30.
Generation and characterization of epidermolysis bullosa simplex cell lines: scratch assays show faster migration with disruptive keratin mutations
Morley S. M., D'Alessandro M., Sexton C., Rugg E. L., Navsaria H., Shemanko C. S., Huber M., Hohl D., Heagerty A. I., Leigh I. M. et al., 2003/07. British Journal of Dermatology, 149 (1) pp. 46-58.
Novel mutations in the gene encoding secreted lymphocyte antigen-6/urokinase-type plasminogen activator receptor-related protein-1 (SLURP-1) and description of five ancestral haplotypes in patients with Mal de Meleda
Marrakchi S., Audebert S., Bouadjar B., Has C., Lefevre C., Munro C., Cure S., Jobard F., Morlot S., Hohl D. et al., 2003/03. Journal of Investigative Dermatology, 120 (3) pp. 351-5.
Le Pseudomonas Hot Foot Syndrome: cas particulier d 'hidradénite eccrine plantaire juvénile
Laffitte E., Hohl D., Panizzon R. G., 2003. Dermatologie pratique, 275 pp. 6-7.
Erythrokeratodermia variabilis with erythema gyratum repens-like lesions
Landau M., Cohen-Bar-Dayan M., Hohl D., Ophir J., Wolf C. R., Gat A., Mevorah B., 2002/08. Pediatric Dermatology, 19 (4) pp. 285-92.
The estrogen-responsive B box protein: a novel regulator of keratinocyte differentiation.
Beer H.D., Munding C., Dubois N., Mamie C., Hohl D., Werner S., 2002/06. Journal of Biological Chemistry, 277 (23) pp. 20740-20749. Peer-reviewed.
Deletion of the cytoplasmatic domain of BP180/collagen XVII causes a phenotype with predominant features of epidermolysis bullosa simplex
Huber M., Floeth M., Borradori L., Schacke H., Rugg E. L., Lane E. B., Frenk E., Hohl D., Bruckner-Tuderman L., 2002/01. Journal of Investigative Dermatology, 118 (1) pp. 185-92.
Disorders of Keratinization. Chapter 24. 2nd edition of Connective Tissue and Its Heritable Disorders
Arin M. J., Hohl D., Roop R. D., 2002..
High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study.
Rodondi N., Darioli R., Ramelet A.A., Hohl D., Lenain V., Perdrix J., Wietlisbach V., Riesen W.F., Walther T., Medinger L. et al., 2002. Annals of Internal Medicine, 136 (8) pp. 582-589. Peer-reviewed.
Le bébé collodion : attitude clinique et pathogénie moléculaire
Hohl D., 2002. Dermatologica Helevetica, 1 pp. 27-28.
Mal de Meleda: genetic haplotype analysis and clinicopathological findings in cases originating from the island of Mljet (Meleda), Croatia
Bakija-Konsuo A., Basta-Juzbasic A., Rudan I., Situm M., Nardelli-Kovacic M., Levanat S., Fischer J., Hohl D., Loncaric D., Seiwert S. et al., 2002. Dermatology, 205 (1) pp. 32-9.
Nail lesions in psoriatic arthritis: recovery with sulfasalazine treatment.
Gerster J.C., Hohl D., 2002. Annals of the Rheumatic Diseases, 61 (3) p. 277. Peer-reviewed.
Novel and recurrent mutations in the genes encoding keratins K6a, K16 and K17 in 13 cases of pachyonychia congenita
Terrinoni A., Smith F. J., Didona B., Canzona F., Paradisi M., Huber M., Hohl D., David A., Verloes A., Leigh I. M. et al., 2001/12. Journal of Investigative Dermatology, 117 (6) pp. 1391-6.
A novel Q378X mutation exists in the transmembrane transporter protein ABCC6 and its pseudogene: implications for mutation analysis in pseudoxanthoma elasticum
Cai L., Lumsden A., Guenther U. P., Neldner S. A., Zach S., Knoblauch H., Ramesar R., Hohl D., Callen D. F., Neldner K. H. et al., 2001/09. Journal of Molecular Medicine, 79 (9) pp. 536-46.
Mutations in the gene encoding SLURP-1 in Mal de Meleda
Fischer J., Bouadjar B., Heilig R., Huber M., Lefevre C., Jobard F., Macari F., Bakija-Konsuo A., Ait-Belkacem F., Weissenbach J. et al., 2001/04. Human Molecular Genetics, 10 (8) pp. 875-80.
Syringocystadenoma papilliferum: a study of potential tumor suppressor genes
Boni R., Xin H., Hohl D., Panizzon R., Burg G., 2001/04. American Journal of Dermatopathology, 23 (2) pp. 87-9.
Acné: mieux se soigner
Harms M., Hohl D., 2001. Le Fait médical, 46 pp. 2-3.
Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.
Naumann M., Lowe N.J., 2001. BMJ, 323 (7313) pp. 596-599. Peer-reviewed.
Towards a better classification of erythrokeratodermias
Hohl D., 2000/12. British Journal of Dermatology, 143 (6) pp. 1133-7.
Expression of small proline rich proteins in neoplastic and inflammatory skin diseases
De Heller-Milev M., Huber M., Panizzon R., Hohl D., 2000/10. British Journal of Dermatology, 143 (4) pp. 733-40.
Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein
Koch P. J., de Viragh P. A., Scharer E., Bundman D., Longley M. A., Bickenbach J., Kawachi Y., Suga Y., Zhou Z., Huber M. et al., 2000/10. Journal of Cell Biology, 151 (2) pp. 389-400.
Epidermal growth factor and keratinocyte growth factor differentially regulate epidermal migration, growth, and differentiation
Gibbs S., Silva Pinto A. N., Murli S., Huber M., Hohl D., Ponec M., 2000/06. Wound Repair and Regeneration, 8 (3) pp. 192-203.
Efficient in vitro transfection of human keratinocytes with an adenovirus-enhanced receptor-mediated system
Huber M., Limat A., Wagner E., Hohl D., 2000/04. Journal of Investigative Dermatology, 114 (4) pp. 661-6.
A 500-kb region on chromosome 16p13.1 contains the pseudoxanthoma elasticum locus: high-resolution mapping and genomic structure
Cai L., Struk B., Adams M. D., Ji W., Haaf T., Kang H. L., Dho S. H., Xu X., Ringpfeil F., Nancarrow J. et al., 2000. Journal of Molecular Medicine, 78 (1) pp. 36-46.
Bullosis diabeticorum in a newly discovered type 2 diabetes mellitus
Derighetti M., Hohl D., Krayenbuhl B. H., Panizzon R. G., 2000. Dermatology, 200 (4) pp. 366-7.
Identification of the familial cylindromatosis tumour-suppressor gene.
Bignell G.R., Warren W., Seal S., Takahashi M., Rapley E., Barfoot R., Green H., Brown C., Biggs P.J., Lakhani S.R. et al., 2000. Nature Genetics, 25 (2) pp. 160-165. Peer-reviewed.
Linkage and LOH studies in 19 cylindromatosis families show no evidence of genetic heterogeneity and refine the CYLD locus on chromosome 16q12-q13
Takahashi M., Rapley E., Biggs P. J., Lakhani S. R., Cooke D., Hansen J., Blair E., Hofmann B., Siebert R., Turner G. et al., 2000/01. Human Genetics, 106 (1) pp. 58-65.
Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis.
Macari F., Landau M., Cousin P., Mevorah B., Brenner S., Panizzon R., Schorderet D.F., Hohl D., Huber M., 2000. American journal of human genetics, 67 (5) pp. 1296-301. Peer-reviewed.
Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticum
Struk B., Cai L., Zach S., Ji W., Chung J., Lumsden A., Stumm M., Huber M., Schaen L., Kim C. A. et al., 2000. Journal of Molecular Medicine, 78 (5) pp. 282-6.
ATP2A2 mutations in Darier's disease: variant cutaneous phenotypes are associated with missense mutations, but neuropsychiatric features are independent of mutation class
Ruiz-Perez V. L., Carter S. A., Healy E., Todd C., Rees J. L., Steijlen P. M., Carmichael A. J., Lewis H. M., Hohl D., Itin P. et al., 1999/09. Human Molecular Genetics, 8 (9) pp. 1621-30.
Hair shaft defects visualized after detergent extraction
Rice R. H., Wong V. J., Williams M. L., Price V. H., Hohl D., Sundberg J. P., Pinkerton K. E., 1999/08. Experimental Dermatology, 8 (4) pp. 308-10.
Periderm cells form cornified cell envelope in their regression process during human epidermal development
Akiyama M., Smith L. T., Yoneda K., Holbrook K. A., Hohl D., Shimizu H., 1999/06. Journal of Investigative Dermatology, 112 (6) pp. 903-9.
A novel substitution in keratin 10 in epidermolytic hyperkeratosis
Arin M. J., Longley M. A., Anton-Lamprecht I., Kurze G., Huber M., Hohl D., Rothnagel J. A., Roop D. R., 1999/04. Journal of Investigative Dermatology, 112 (4) pp. 506-8.
An asparagine to threonine substitution in the 1A domain of keratin 1: a novel mutation that causes epidermolytic hyperkeratosis
Arin M. J., Longley M. A., Kuster W., Huber M., Hohl D., Rothnagel J. A., Roop D. R., 1999/04. Experimental Dermatology, 8 (2) pp. 124-7.
Kératodermies palmo-plantaires
Görög J. P., Hohl D., 1999..
Les ichtyoses héréditaires
Hohl D., Schnyder U., 1999..
Les épidermolyses bulleuses : mécanismes moléculaires et prise en charge clinique
Hohl D., Borradori L., 1999. Médecine et Hygiène, 57 (2254) pp. 953-958.
Physiopathologie de la kératinisation
Hohl D., 1999..
Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis
Richard G., Smith L. E., Bailey R. A., Itin P., Hohl D., Epstein, E. H., Jr. , DiGiovanna J. J., Compton J. G., Bale S. J., 1998/12. Nature Genetics, 20 (4) pp. 366-9.
In vitro and rapid in situ transglutaminase assays for congenital ichthyoses--a comparative study
Hohl D., Aeschlimann D., Huber M., 1998/03. Journal of Investigative Dermatology, 110 (3) pp. 268-71.
Linkage studies in erythrokeratodermias: fine mapping, genetic heterogeneity and analysis of candidate genes
Richard G., Lin J. P., Smith L., Whyte Y. M., Itin P., Wollina U., Epstein, E., Jr. , Hohl D., Giroux J. M., Charnas L. et al., 1997/11. Journal of Investigative Dermatology, 109 (5) pp. 666-71.
Consequences of seven novel mutations on the expression and structure of keratinocyte transglutaminase
Huber M., Yee V. C., Burri N., Vikerfors E., Lavrijsen A. P., Paller A. S., Hohl D., 1997/08. Journal of Biological Chemistry, 272 (34) pp. 21018-26.
Three novel point mutations in the keratinocyte transglutaminase (TGK) gene in lamellar ichthyosis: significance for mutant transcript level, TGK immunodetection and activity
Petit E., Huber M., Rochat A., Bodemer C., Teillac-Hamel D., Muh J. P., Revuz J., Barrandon Y., Lathrop M., de Prost Y. et al., 1997/08. European Journal of Human Genetics, 5 (4) pp. 218-28.
Prenatal diagnosis of lamellar ichthyosis by direct mutational analysis of the keratinocyte transglutaminase gene
Schorderet D. F., Huber M., Laurini R. N., Von Moos G., Gianadda B., Deleze G., Hohl D., 1997/05. Prenatal Diagnosis, 17 (5) pp. 483-6.
A novel dinucleotide mutation in keratin 10 in the annular epidermolytic ichthyosis variant of bullous congenital ichthyosiform erythroderma
Joh G. Y., Traupe H., Metze D., Nashan D., Huber M., Hohl D., Longley M. A., Rothnagel J. A., Roop D. R., 1997/03. Journal of Investigative Dermatology, 108 (3) pp. 357-61.
Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex
Smith F. J., Corden L. D., Rugg E. L., Ratnavel R., Leigh I. M., Moss C., Tidman M. J., Hohl D., Huber M., Kunkeler L. et al., 1997/02. Journal of Investigative Dermatology, 108 (2) pp. 220-3.
Steatocystoma multiplex and oligosymptomatic pachyonychia congenita of the Jackson-Sertoli type
Hohl D., 1997. Dermatology, 195 (1) pp. 86-8.
Cuticle cell defects in lamellar ichthyosis hair and anomalous hair shaft syndromes visualized after detergent extraction
Rice R. H., Wong V. J., Price V. H., Hohl D., Pinkerton K. E., 1996/12. Anatomical Record, 246 (4) pp. 433-40.
Specificity of B.C1 for TGK after renaturation prior to transfer of proteins
Hohl D., Rettler I., Huber M., 1996/04. Journal of Investigative Dermatology, 106 (4) pp. 801-3.
Ichthyosiform dermatosis with superficial blister formation and peeling: evidence for a desmosomal anomaly and altered epidermal vitamin A metabolism
Mevorah B., Salomon D., Siegenthaler G., Hohl D., Meier M. L., Saurat J. H., Frenk E., 1996/02. Journal of the American Academy of Dermatology, 34 (2 Pt 2) pp. 379-85.
Immunoelectron microscopic analysis of cornified cell envelope formation in normal and psoriatic epidermis
Ishida-Yamamoto A., Eady R. A., Watt F. M., Roop D. R., Hohl D., Iizuka H., 1996/02. Journal of Histochemistry and Cytochemistry, 44 (2) pp. 167-75.
Genetic heterogeneity in lamellar ichthyosis.
Bale S.J., Compton J.G., Russell L.J., DiGiovanna J.J., 1996. Journal of Investigative Dermatology, 107 (1) pp. 140-141. Peer-reviewed.
Meleda disease: report of two cases investigated by electron microscopy
Frenk E., Guggisberg D., Mevorah B., Hohl D., 1996. Dermatology, 193 (4) pp. 358-61.
Lamellar ichthyosis is genetically heterogeneous--cases with normal keratinocyte transglutaminase
Huber M., Rettler I., Bernasconi K., Wyss M., Hohl D., 1995/11. Journal of Investigative Dermatology, 105 (5) pp. 653-4.
Acquisitions recentes sur la carcinogenese epidermique. [Current knowledge of epidermal carcinogenesis]
Hohl D., 1995/10. Revue Médicale de la Suisse Romande, 115 (10) pp. 747-52.
Giant recurrence of a multiple agminated Spitz nevus
Krasovec M., Gianadda B., Hohl D., 1995/08. Journal of the American Academy of Dermatology, 33 (2 Pt 2) pp. 386-8.
The small proline-rich proteins constitute a multigene family of differentially regulated cornified cell envelope precursor proteins
Hohl D., de Viragh P. A., Amiguet-Barras F., Gibbs S., Backendorf C., Huber M., 1995/06. Journal of Investigative Dermatology, 104 (6) pp. 902-9.
Mutations in the 1A domain of keratin 9 in patients with epidermolytic palmoplantar keratoderma
Rothnagel J. A., Wojcik S., Liefer K. M., Dominey A. M., Huber M., Hohl D., Roop D. R., 1995/03. Journal of Investigative Dermatology, 104 (3) pp. 430-3.
Altered distribution of keratinization markers in epidermolytic hyperkeratosis
Ishida-Yamamoto A., Iizuka H., Manabe M., O'Guin W. M., Hohl D., Kartasova T., Kuroki T., Roop D. R., Eady R. A., 1995. Archives for Dermatological Research (Archiv fur Dermatologische Forschung), 287 (8) pp. 705-11.
Genodermatoses de l'epiderme resultant de mutations des keratines. [Inherited abnormalities of the epidermis caused by mutation of keratins]
Hohl D., 1995. Annales de Dermatologie et de Venereologie, 122 (4) pp. 162-6.
Intraepidermal IgA pustulosis preceding a CD30+ anaplastic large T-cell lymphoma
Guggisberg D., Hohl D., 1995. Dermatology, 191 (4) pp. 352-4.
Modification of late epidermal differentiation in photoaged skin treated with topical retinoic acid cream
Tur E., Hohl D., Jetten A., Panizzon R., Frenk E., 1995. Dermatology, 191 (2) pp. 124-8.
Mutations of keratinocyte transglutaminase in lamellar ichthyosis
Huber M., Rettler I., Bernasconi K., Frenk E., Lavrijsen S. P., Ponec M., Bon A., Lautenschlager S., Schorderet D. F., Hohl D., 1995/01. Science, 267 (5197) pp. 525-8.
Involucrin mRNA is more abundant in human hair follicles than in normal epidermis
de Viragh P. A., Huber M., Hohl D., 1994/12. Journal of Investigative Dermatology, 103 (6) pp. 815-9.
Mutations in the rod domain of keratin 2e in patients with ichthyosis bullosa of Siemens
Rothnagel J. A., Traupe H., Wojcik S., Huber M., Hohl D., Pittelkow M. R., Saeki H., Ishibashi Y., Roop D. R., 1994/08. Nature Genetics, 7 (4) pp. 485-90.
Abnormal keratin 1 and 10 cytoskeleton in cultured keratinocytes from epidermolytic hyperkeratosis caused by keratin 10 mutations.
Huber M., Scaletta C., Benathan M., Frenk E., Greenhalgh D.A., Rothnagel J.A., Roop D.R., Hohl D., 1994/05. Journal of Investigative Dermatology, 102 (5) pp. 691-694. Peer-reviewed.
Les genodermatoses epidermiques: modeles d'approche modernes de la dermatologie. [Epidermic genodermatoses: models of current approch in dermatology]
Hohl D., 1994/03. Revue Médicale de la Suisse Romande, 114 (3) pp. 277-80.
Necrotizing vascular calcinosis
Hohl D., 1994. Dermatology, 189 (4) pp. 432-4.
Patient satisfaction in home care/hospice
Hohl D., 1994/01. Nurs Manage, 25 (1) pp. 52-4.
A mutational hot spot in keratin 10 (KRT 10) in patients with epidermolytic hyperkeratosis
Rothnagel J. A., Fisher M. P., Axtell S. M., Pittelkow M. R., Anton-Lamprecht I., Huber M., Hohl D., Roop D. R., 1993/12. Human Molecular Genetics, 2 (12) pp. 2147-50.
Annular bullous eruption in a patient with the CREST syndrome, primary biliary cirrhosis, and Sjogren's syndrome
Borradori L., Hohl D., Rochat P., Frenk E., 1993/10. Journal of the American Academy of Dermatology, 29 (4) pp. 648-50.
Expression patterns of loricrin in various species and tissues
Hohl D., Ruf Olano B., de Viragh P. A., Huber M., Detrisac C. J., Schnyder U. W., Roop D. R., 1993/08. Differentiation, 54 (1) pp. 25-34.
Analysis of the cornified cell envelope in lamellar ichthyosis
Hohl D., Huber M., Frenk E., 1993/05. Archives of Dermatology, 129 (5) pp. 618-24.
Expression patterns of loricrin in dermatological disorders
Hohl D., 1993/02. American Journal of Dermatopathology, 15 (1) pp. 20-7.
Bullous systemic lupus erythematosus. Report of a case with lupus erythematosus cells in the dermis
Borradori L., Hohl D., Monteil M., Frenk E., 1993. Dermatology, 187 (4) pp. 306-8.
Loricrin immunoreactivity in human skin: localization to specific granules (L-granules) in acrosyringia
Ishida-Yamamoto A., Hohl D., Roop D. R., Iizuka H., Eady R. A., 1993. Archives for Dermatological Research (Archiv fur Dermatologische Forschung), 285 (8) pp. 491-8.
The Nageli-Franceschetti-Jadassohn syndrome: A hereditary ectodermal defect leading to colloid-amyloid formation in the dermis
Frenk E., Mevorah B., Hohl D., 1993. Dermatology, 187 (3) pp. 169-73.
A common origin for cornified envelope proteins?
Backendorf C., Hohl D., 1992/10. Nature Genetics, 2 (2) p. 91.
The human loricrin gene.
Yoneda K., Hohl D., McBride O.W., Wang M., Cehrs K.U., Idler W.W., Steinert P.M., 1992/09. Journal of Biological Chemistry, 267 (25) pp. 18060-18066. Peer-reviewed.
Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis
Rothnagel J. A., Dominey A. M., Dempsey L. D., Longley M. A., Greenhalgh D. A., Gagne T. A., Huber M., Frenk E., Hohl D., Roop D. R., 1992/08. Science, 257 (5073) pp. 1128-30.
Erythema nodosum und AIDS. [Erythema nodosum and AIDS]
Hohl D., Gueissaz F., Gerain J., Frenk E., 1992/02. Hautarzt, 43 (2) pp. 86-8.
A prospective study of skeletal changes during short-term acitretin therapy
Hohl D., Pelloni F., Sigg C., Gilardi S., Jung T., 1992. Dermatology, 185 (1) pp. 23-6.
Characterization of human loricrin. Structure and function of a new class of epidermal cell envelope proteins.
Hohl D., Mehrel T., Lichti U., Turner M.L., Roop D.R., Steinert P.M., 1991/04. Journal of Biological Chemistry, 266 (10) pp. 6626-6636. Peer-reviewed.
Transcription of the human loricrin gene in vitro is induced by calcium and cell density and suppressed by retinoic acid
Hohl D., Lichti U., Breitkreutz D., Steinert P. M., Roop D. R., 1991/04. Journal of Investigative Dermatology, 96 (4) pp. 414-8.
Nodular cutaneous mucinosis--an unusual multiple type of euthyreotic focal mucinosis
Schneider B. V., Hohl D., Schnyder U. W., 1991. Dermatologica, 183 (1) pp. 73-6.
Ein neuer Stern am Himmel der epidermalen Proteine: Loricrin--was ist das? [A new star in the heavens of epidermal proteins: loricrin--what is it?]
Hohl D., 1990/06. Hautarzt, 41 (6) pp. 299-301.
Identification of a major keratinocyte cell envelope protein, loricrin
Mehrel T., Hohl D., Rothnagel J. A., Longley M. A., Bundman D., Cheng C., Lichti U., Bisher M. E., Steven A. C., Steinert P. M. et al., 1990/06. Cell, 61 (6) pp. 1103-12.
Cornified cell envelope
Hohl D., 1990. Dermatologica, 180 (4) pp. 201-11.
Dermatitis herpetiformis in a patient with acquired immunodeficiency syndrome-related complex
Mitsuhashi Y., Hohl D., 1988/03. Journal of the American Academy of Dermatology, 18 (3) p. 583.
Pemphigus vulgaris mit Oesophagus-Beteiligung. Fallbericht und Literaturubersicht. [Pemphigus vulgaris with esophageal involvement. Case report and review of the literature]
Hohl D. M., Mitsuhashi Y., 1987/09. Hautarzt, 38 (9) pp. 536-40.
Unicentre - CH-1015 Lausanne
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University